At a glance
- Originator Schering-Plough
- Class Anti-inflammatories; Antiasthmatics; Benzamides; Oximes
- Mechanism of Action Neurokinin 1 antagonists; Neurokinin 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 18 Dec 2003 No development reported - Preclinical for Asthma in USA (PO)
- 13 Sep 2000 New profile
- 13 Sep 2000 Preclinical development for Asthma in USA (PO)